½ÃÀ庸°í¼­
»óǰÄÚµå
1589265

¼¼°èÀÇ ¹æ±¤°æ °Ë»ç ½ÃÀå : À¯Çü, Á¦Ç°, ÃÖÁ¾ »ç¿ëÀÚº° ¿¹Ãø(2025-2030³â)

Cystoscopy Market by Type (Flexible Cystoscopy, Rigid Cystoscopy), Product (Fiber Cystoscopy, Video Cystoscopy), End User - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 186 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

¹æ±¤°æ °Ë»ç ½ÃÀåÀº 2023³â 14¾ï 4,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³â¿¡´Â 15¾ï 7,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 9.07%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 26¾ï 5,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¹æ±¤°æ °Ë»ç´Â ¹æ±¤°æ¿¡ ÀÇÇÑ ¹æ±¤°ú ¿äµµ °Ë»ç¸¦ Æ÷ÇÔÇÑ Áø´Ü°ú Ä¡·á ÀýÂ÷ÀÔ´Ï´Ù. ±× ¿ëµµ´Â À°¾È °Ë»ç¿¡¼­ »ý°Ë, ¹æ±¤ ¹®Á¦ÀÇ Ä¡·á±îÁö ´Ù¾çÇÕ´Ï´Ù. ÃÖÁ¾ ¿ëµµÀÇ ¹üÀ§´Â º´¿ø, Ŭ¸®´Ð, ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC) ¹× ºñ´¢±â°ú Áúȯ Áõ°¡¿Í ³·Àº ħ½À ±â¼úÀÇ Áøº¸·Î ä¿ëÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌȯÀ² »ó½Â, ÀÎÁöµµ Çâ»ó°ú Á¶±â ±â°£ Áø´Ü Ä·ÆäÀΰú °°Àº ¸î °¡Áö ÁÖ¿ä ¼ºÀå ¿äÀÎÀÌ ¹àÇôÁ³½À´Ï´Ù. Çʿ伺ÀÌ °¨¿°À̳ª »óÇØ µîÀÇ ÀáÀç ÇÕº´Áõ°ú ÇÔ²² Á¦¾àÀ» ¹Þ°í ÀÖ½À´Ï´Ù. ½ÃÀåÀº ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀΰú °¡°Ý °æÀï ¾Ð·Â¿¡ ´ëÇÑ °úÁ¦¿¡µµ Á÷¸éÇϰí ÀÖ½À´Ï´Ù. ¿¡ ÀÖÀ¸¸ç ¿ø°Ý ÀÇ·á ÅëÇÕ ¹× ºñ¿ë È¿À²ÀûÀÎ Çõ½Å¿¡ ÀÇÇØ ¹æ±¤°æ °Ë»çÀÇ µµÀÔÀÌ °¡¼ÓµÉ °¡´É¼ºÀÌ ÀÖ½À´Ï´Ù. ÅëÇÕ µû¶ó¼­ °æÀï ¿ìÀ§¸¦ Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ È¯ÀÚÀÇ Æí¾ÈÇÔÀ» Ãß±¸ÇÏ°í ¼ö¼úÀÇ Ä§½À¼ºÀ» ÁÙÀÌ´Â Á¶»çµµ ¼ºÀåÀ» °¡¼ÓÇÒ ¼ö ÀÖ½À´Ï´Ù. Áö¼ÓÀûÀÎ R&D ÅõÀڷΠźźÇÑ Çõ½Å ÆÄÀÌÇÁ¶óÀÎÀÌ È®º¸µÇ¾î ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼÷·ÃµÈ Àü¹®°¡ÀÇ ºÎÁ·À» ¿ÏÈ­Çϱâ À§ÇÑ ±³À° ÇÁ·Î±×·¥¿¡ ÅõÀÚÇϰųª º¸´Ù ÁÁÀº µµ´ÞÁ¡À» ¾ò±â À§ÇØ ÀÇ·á±â°ü°ú Á¦ÈÞÇÔÀ¸·Î½á À̸¦ Ȱ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ¼Ò±Ô¸ð Ŭ¸®´ÐÀ» À§ÇÑ ÈÞ´ë °¡´ÉÇÏ°í »ç¿ëÇϱ⠽¬¿î Àåºñ °³¹ß°ú ȯÀÚÀÇ Àü¹ÝÀûÀÎ °æÇè°ú ¸¸Á·µµ¸¦ Çâ»ó½Ã۱â À§ÇÑ Ä¡·á ÈÄ °ü¸® ¼Ö·ç¼Ç °­È­¿¡ ÁÖ·ÂÇÔÀ¸·Î½á ¼ºÀåÀ» °¡¼ÓÇÏ°í ½ÃÀå¿¡¼­ÀÇ ÁöÀ§ È®°íÇÑ ÀÏÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ (2023³â) 14¾ï 4,000¸¸ ´Þ·¯
¿¹Ãø³â(2024³â) 15¾ï 7,000¸¸ ´Þ·¯
¿¹Ãø³â(2030³â) 26¾ï 5,000¸¸ ´Þ·¯
º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR)(%) 9.07%

½ÃÀå ¿ªÇÐ : ±Þ¼ÓÈ÷ ÁøÈ­ÇÏ´Â ¹æ±¤°æ °Ë»ç ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

¹æ±¤°æ °Ë»ç ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ð¸¦ ÀÌ·ç°í ÀÖ½À´Ï´Ù. »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ ȹµæÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ À§ÇèÀ» ¿ÏÈ­ÇÒ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë°ú ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ»º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ¿ä·Î °¨¿°ÀÇ ³ôÀº À¯Çà·ü
    • ºñ´¢±â°ú¿¡¼­ ¹æ±¤°æ °Ë»çÀÇ »ç¿ë¿¡ ´ëÇÑ ÀÇ½Ä Áõ°¡
    • °¢±¹ÀÇ ³ëÀÎ Áõ°¡
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ¹æ±¤°æ °Ë»ç¸¦ ½Ç½ÃÇϱâ À§ÇÑ Àü¹® Áö½ÄÀÇ ºÎÁ·
  • ½ÃÀå ±âȸ
    • º´¿ø¿¡ ÀÇÇÑ ³»½Ã°æ °Ë»ç¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡
    • È­»ó ±â¼úÀÇ ¼ºÀå¿¡ À־ÀÇ ±Þ¼ÓÇÑ ±â¼ú Áøº¸
  • ½ÃÀåÀÇ °úÁ¦
    • ¹æ±¤°æ °Ë»ç¿¡ ÀÇÇÑ °¨¿°ÀÇ À§Çù

Porter's Five Forces : ¹æ±¤°æ °Ë»ç ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Forces Framework´Â ¹æ±¤°æ °Ë»ç ½ÃÀå °æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ¸¦ ±âÀçÇϰí ÀÖ½À´Ï´Ù. K´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÇÇÇÒ ¼ö ÀÖÀ¸¸ç ´õ °­ÀÎÇÑ ½ÃÀå¿¡¼­ Æ÷Áö¼Å´×À» º¸Àå ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ¹æ±¤°æ °Ë»ç ½ÃÀåÀÇ ¿ÜºÎ ¿µÇâÀ» ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ¹æ±¤°æ °Ë»ç ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ°¡µÇ¾î ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : ¹æ±¤°æ °Ë»ç ½ÃÀå °æÀï ±¸µµ ÆÄ¾Ç

¹æ±¤°æ °Ë»ç ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¹àÈ÷´Ù ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁß, ºÎ¹®È­ ¹× ÅëÇÕ µ¿ÇâÀ» ¹àÇô³»°í, º¥´õ´Â °æÀïÀÌ °ÝÈ­µÇ´Â °¡¿îµ¥ ÀÚ½ÅÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» Çϱâ À§ÇØ ÇÊ¿äÇÑ Áö°ßÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : ¹æ±¤°æ °Ë»ç ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ¹æ±¤°æ °Ë»ç ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ¿¡ µû¶ó °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ³× °¡Áö »çºÐ¸éÀ» ÅëÇØ º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ºÐÇÒÇϰí Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ: ¹æ±¤°æ °Ë»ç ½ÃÀå¿¡¼­ ¼º°øÀ» À§ÇÑ ±æÀ» ±×¸®±â

¹æ±¤°æ½ÃÇè ½ÃÀåÀÇ Àü·«ºÐ¼®Àº ½ÃÀå¿¡¼­ÀÇ ÇÁ·¹Á𽺠°­È­¸¦ ¸ñÇ¥·Î ÇÏ´Â ±â¾÷¿¡ ÇʼöÀûÀÔ´Ï´Ù. ÀÌ Á¢±Ù¹ýÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ üÁ¦¸¦ ¸¶·ÃÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ ´Ù·ç´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·ÂÀ» Æò°¡ÇÕ´Ï´Ù.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÎ¹®¿¡¼­ÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» ¼³¸íÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, »ê¾÷ÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾ò°í ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡µµ ´ë´äÇϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ, ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ¿ä·Î °¨¿°ÀÇ ¹ß»ý·üÀÌ ³ô´Ù
      • ºñ´¢±â°ú¿¡¼­ ¹æ±¤°æ °Ë»çÀÇ »ç¿ë¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡
      • °æÁ¦¿¡¼­ ³ëÀÎ Áõ°¡
    • ¾ïÁ¦¿äÀÎ
      • ¹æ±¤°æ °Ë»ç¸¦ ¼öÇàÇϱâ À§ÇÑ Àü¹® Áö½ÄÀÌ ºÎÁ·
    • ±âȸ
      • º´¿ø¿¡ ÀÇÇÑ ³»½Ã°æ °Ë»ç¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡
      • À̹Ì¡ ±â¼úÀÇ ±Þ¼ÓÇÑ Áøº¸
    • °úÁ¦
      • ¹æ±¤°æ °Ë»ç¿¡ ÀÇÇÑ °¨¿°ÀÇ À§Çù
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå ¹æ±¤°æ °Ë»ç ½ÃÀå : À¯Çüº°

  • ¼Ò°³
  • ¿¬¼º ¹æ±¤°æ °Ë»ç
  • °æ¼º ¹æ±¤°æ °Ë»ç

Á¦7Àå ¹æ±¤°æ °Ë»ç ½ÃÀå : Á¦Ç°º°

  • ¼Ò°³
  • ¼¶À¯ ¹æ±¤°æ °Ë»ç
  • ºñµð¿À ¹æ±¤°æ °Ë»ç

Á¦8Àå ¹æ±¤°æ °Ë»ç ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • ¼Ò°³
  • µ¿¹°
  • Àΰ£

Á¦9Àå ¾Æ¸Þ¸®Ä«ÀÇ ¹æ±¤°æ °Ë»ç ½ÃÀå

  • ¼Ò°³
  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦10Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ¹æ±¤°æ °Ë»ç ½ÃÀå

  • ¼Ò°³
  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦11Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ¹æ±¤°æ °Ë»ç ½ÃÀå

  • ¼Ò°³
  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦12Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®(2023³â)
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º(2023³â)
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸ñ·Ï

  • Ackermann Instrumente GmbH
  • Boston Scientific Corporation
  • Careforde Inc.
  • Coloplast Corporation
  • Cook Group Incorporated
  • Gemini Medical Technologies LLC
  • Island Health
  • Karl Storz Gmbh & Co.kg
  • LABORIE MEDICAL TECHNOLOGIES CORP.
  • Medtronic PLC
  • Olympus Corporation
  • Ottomed
  • PENTAX Medical by Hoya Corporation
  • Richard Wolf GmbH
  • Shenyang Shenda Endoscope Co. Ltd.
  • Stryker Corporation
BJH 24.11.21

The Cystoscopy Market was valued at USD 1.44 billion in 2023, expected to reach USD 1.57 billion in 2024, and is projected to grow at a CAGR of 9.07%, to USD 2.65 billion by 2030.

Cystoscopy is a diagnostic and therapeutic procedure involving the examination of the bladder and urethra with a cystoscope. Its necessity stems from its ability to accurately diagnose conditions such as urinary tract infections, bladder cancer, and kidney stones, while its applications range from visual inspection to biopsy and treatment of bladder issues. The end-use scope spans hospitals, clinics, and ambulatory surgical centers, with increasing adoption due to rising urological disorders and advancements in minimally invasive technologies. Market insights reveal several key growth factors, including the aging population's susceptibility to urological diseases and increasing awareness and early diagnosis campaigns. The procedural efficiency and reduced recovery times further bolster its adoption. However, high procedural costs and the need for skilled professionals pose limitations, alongside potential complications like infections or injury. The market also faces challenges related to regulatory approvals and competitive pricing pressures. Nevertheless, opportunities abound in emerging economies with inadequate healthcare infrastructure, where telemedicine integration and cost-effective innovations can accelerate cystoscopy adoption. Technological advancements like robotic-assisted cystoscopies and the development of single-use cystoscopes are promising areas for innovation. Incorporating AI for better diagnostic accuracy and predictive analytics can offer a competitive advantage. Research into patient comfort and reducing procedural invasiveness could also drive growth. The market exhibits a dynamic nature, with ongoing R&D investments ensuring a robust innovation pipeline. Businesses can capitalize on this by investing in training programs to mitigate the shortage of skilled professionals and by partnering with healthcare institutions for better reach. Companies can foster growth by focusing on developing portable and user-friendly devices for small-scale clinics and enhancing post-procedural care solutions to improve overall patient experience and satisfaction, thereby solidifying their market position.

KEY MARKET STATISTICS
Base Year [2023] USD 1.44 billion
Estimated Year [2024] USD 1.57 billion
Forecast Year [2030] USD 2.65 billion
CAGR (%) 9.07%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cystoscopy Market

The Cystoscopy Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • High prevalence in incidences of urinary tract infections
    • Growing awareness about the usage of cystoscopy in urology
    • Rising geriatric population in economies
  • Market Restraints
    • Lack of expertise to perform cystoscopy
  • Market Opportunities
    • Rising investments in endoscopy by hospitals
    • Rapid technological advancement in the growth of imaging technology
  • Market Challenges
    • Threat of infection due to cystoscopy

Porter's Five Forces: A Strategic Tool for Navigating the Cystoscopy Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cystoscopy Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cystoscopy Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cystoscopy Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cystoscopy Market

A detailed market share analysis in the Cystoscopy Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cystoscopy Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cystoscopy Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cystoscopy Market

A strategic analysis of the Cystoscopy Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cystoscopy Market, highlighting leading vendors and their innovative profiles. These include Ackermann Instrumente GmbH, Boston Scientific Corporation, Careforde Inc., Coloplast Corporation, Cook Group Incorporated, Gemini Medical Technologies LLC, Island Health, Karl Storz Gmbh & Co.kg, LABORIE MEDICAL TECHNOLOGIES CORP., Medtronic PLC, Olympus Corporation, Ottomed, PENTAX Medical by Hoya Corporation, Richard Wolf GmbH, Shenyang Shenda Endoscope Co., Ltd., and Stryker Corporation.

Market Segmentation & Coverage

This research report categorizes the Cystoscopy Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Flexible Cystoscopy and Rigid Cystoscopy.
  • Based on Product, market is studied across Fiber Cystoscopy and Video Cystoscopy.
  • Based on End User, market is studied across Animals and Human.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. High prevalence in incidences of urinary tract infections
      • 5.1.1.2. Growing awareness about the usage of cystoscopy in urology
      • 5.1.1.3. Rising geriatric population in economies
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of expertise to perform cystoscopy
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising investments in endoscopy by hospitals
      • 5.1.3.2. Rapid technological advancement in the growth of imaging technology
    • 5.1.4. Challenges
      • 5.1.4.1. Threat of infection due to cystoscopy
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cystoscopy Market, by Type

  • 6.1. Introduction
  • 6.2. Flexible Cystoscopy
  • 6.3. Rigid Cystoscopy

7. Cystoscopy Market, by Product

  • 7.1. Introduction
  • 7.2. Fiber Cystoscopy
  • 7.3. Video Cystoscopy

8. Cystoscopy Market, by End User

  • 8.1. Introduction
  • 8.2. Animals
  • 8.3. Human

9. Americas Cystoscopy Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Cystoscopy Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Cystoscopy Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Ackermann Instrumente GmbH
  • 2. Boston Scientific Corporation
  • 3. Careforde Inc.
  • 4. Coloplast Corporation
  • 5. Cook Group Incorporated
  • 6. Gemini Medical Technologies LLC
  • 7. Island Health
  • 8. Karl Storz Gmbh & Co.kg
  • 9. LABORIE MEDICAL TECHNOLOGIES CORP.
  • 10. Medtronic PLC
  • 11. Olympus Corporation
  • 12. Ottomed
  • 13. PENTAX Medical by Hoya Corporation
  • 14. Richard Wolf GmbH
  • 15. Shenyang Shenda Endoscope Co., Ltd.
  • 16. Stryker Corporation
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦